Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000033

Chief Executive Officer disposed of 195,236 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virnich Daniel Chief Executive Officer 2024-11-12 Other disposition −78,094 838,853 D: show line 1 in the form
Virnich Daniel Chief Executive Officer 2024-11-12 Other disposition −117,142 721,711 D: show line 2 in the form
Loading xslF345X05/wk-form4_1731973827.xml…